|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenues | |
| Revenues from settlement agreement with GEHC (*) | |
| Total revenues | |
| Cost of revenues | |
| Gross profit | |
| Research and development expenses, net | |
| Sales and marketing expenses | |
| General and administrative expenses | |
| Operating loss | |
| Financial expenses | |
| Financial income | |
| Financial expenses (income), net | |
| Loss before income tax | |
| Provision (benefit) for income tax | |
| Net loss and comprehensive loss | |
| Loss per ordinary share - basic | |
| Loss per ordinary share - diluted |
Loading...
